Azoospermia Treatment: Getting Pregnant with Zero Sperm Count

Azoospermia treatment depends on the type. For obstructive azoospermia (blocked ducts, vasectomy, absent vas deferens), sperm are retrieved from the epididymis or testis using PESA or TESA and used in ICSI. Success rates are high. For non-obstructive azoospermia (testicular failure), micro-TESE (microsurgical sperm extraction) finds sperm in 40-60% of cases; if found, ICSI achieves fertilisation. Some NOA cases caused by hormonal disorders or varicocele can be treated medically first, sometimes restoring sperm to the ejaculate. Genetic testing must happen before surgery to guide decisions and counsel on genetic risk to offspring.

Key Takeaways

• Azoospermia (zero sperm in the ejaculate) affects approximately 1% of all men and 10-15% of men presenting with infertility.
• There are two distinct types: obstructive azoospermia (OA), where sperm are produced but blocked, and non-obstructive azoospermia (NOA), where the testes produce insufficient sperm.
• Obstructive azoospermia has the best prognosis. Sperm retrieval rates with PESA or TESA are 90-100%, and live birth rates with ICSI are comparable to non-male factor IVF.
• Non-obstructive azoospermia is more complex. Micro-TESE finds sperm in 40-60% of cases overall, with outcomes varying considerably by underlying cause.
• Genetic testing, including karyotype and Y-chromosome microdeletion analysis, is essential before surgical sperm retrieval. Some genetic profiles (AZFa and AZFb full deletions) predict near-zero chance of finding sperm at surgery, sparing unnecessary procedures.
• A diagnosis of zero sperm count is not a diagnosis of zero options.

Key Terms Defined

Azoospermia: The complete absence of sperm in the ejaculate on two separate semen analyses. Defined by the WHO as zero sperm cells after high-speed centrifugation of the semen sample. It is not the same as low sperm count. See the dedicated azoospermia conditions page for a clinical overview.

Obstructive azoospermia (OA): Azoospermia caused by a blockage anywhere along the male reproductive tract (epididymis, vas deferens, ejaculatory ducts). Sperm production in the testes is typically normal. Accounts for approximately 40% of azoospermia cases.

Non-obstructive azoospermia (NOA): Azoospermia caused by impaired or absent sperm production within the testes themselves. The reproductive tract is open but has no sperm (or insufficient sperm) passing through it. Accounts for approximately 60% of azoospermia cases.

Micro-TESE (microsurgical testicular sperm extraction): The gold-standard surgical procedure for non-obstructive azoospermia. Performed under an operating microscope, it allows the surgeon to identify and harvest sperm-producing tubules (which appear whiter and dilated) while minimising damage to testicular tissue. Sperm retrieval rates are 40-60% overall.

ICSI (intracytoplasmic sperm injection): Requires only a single sperm per egg. A single retrieved sperm is injected directly into the egg under a microscope. It is the fertilisation method used with all surgically retrieved sperm. Read more about ICSI treatment in Hyderabad.

FSH (follicle-stimulating hormone): The pituitary hormone that signals the testes to produce sperm. Elevated FSH in a man with azoospermia indicates that the brain is sending the signal but the testes are not responding, pointing to primary testicular failure (NOA). Normal FSH with azoospermia suggests a blockage or pre-testicular hormonal problem.

The Two Types of Azoospermia: Why the Distinction Matters?

The treatment for azoospermia is entirely different depending on type, which is why classification comes before any discussion of options.

In obstructive azoospermia, the testes are producing sperm normally. The sperm simply cannot reach the ejaculate because of a blockage somewhere along the plumbing. The implication is favourable: sperm are present and available for retrieval. Sperm retrieved from the epididymis in OA are typically mature, motile, and of good quality.

In non-obstructive azoospermia, the problem is at the factory, not the pipes. The testes are either not producing sperm at all (Sertoli cell-only syndrome) or producing very few in isolated pockets of seminiferous tubules. The sperm that do exist are fewer, less mature, and sometimes immotile. Retrieval requires a more invasive surgical search, and there is no guarantee sperm will be found.

Getting this distinction right early saves time, money, and emotional burden. The advanced tests for azoospermia available at Mamata Fertility are designed specifically to make this distinction reliably before any surgical decision.

Causes of Obstructive Azoospermia

Vasectomy is the most common cause of OA worldwide. A deliberate surgical blockage of the vas deferens. Reversal (vasovasostomy) is possible in appropriate candidates; if reversal is not suitable, sperm retrieval combined with ICSI is the primary path to parenthood.

Congenital bilateral absence of the vas deferens (CBAVD): Both vas deferens are absent from birth. Associated with mutations in the CFTR gene (the cystic fibrosis gene). Men with CBAVD cannot have a vasectomy reversal because there is no vas to reconnect. PESA or TESA with ICSI is the only option. Genetic counselling is essential, as CFTR mutations can be passed to children.

Prior infection: Epididymitis or orchitis (often caused by chlamydia, gonorrhoea, or tuberculosis) can cause scarring and blockage of the epididymis or ejaculatory ducts. Mumps orchitis in adulthood can cause both OA and, in severe cases, NOA depending on the extent of testicular damage.

Prior hernia repair: Inadvertent damage to the vas deferens during inguinal hernia repair (especially in childhood) is an under-recognised cause of OA.

Ejaculatory duct obstruction: Blockage at the point where the ducts enter the urethra. Can sometimes be corrected surgically (transurethral resection of the ejaculatory ducts, TURED).

Causes of Non-Obstructive Azoospermia

Klinefelter syndrome (47,XXY): The most common chromosomal cause of NOA, present in approximately 10-15% of NOA cases. Men have two X chromosomes instead of one. Sperm production is severely impaired, but focal pockets of sperm production may exist. Micro-TESE finds sperm in 40-50% of Klinefelter cases.

Y-chromosome microdeletions: Tiny deletions in the AZF (azoospermia factor) region of the Y chromosome are the second most common genetic cause. The clinical significance depends on the deleted region:

• AZFc deletion: Sperm retrieval possible in 50-70% of cases. Micro-TESE is worthwhile.
• AZFb deletion: Sperm retrieval extremely unlikely. Micro-TESE is rarely pursued.
• AZFa deletion: Complete Sertoli cell-only syndrome. Sperm virtually never found at surgery.

This is why Y-chromosome microdeletion testing is not optional in NOA workup. It directly determines whether micro-TESE is likely to succeed.

Hypogonadotropic hypogonadism (HH): The pituitary gland fails to produce adequate FSH and LH, so the testes never receive the hormonal signal to produce sperm. Unlike most other NOA causes, HH is often treatable with gonadotropin injections (hCG + FSH), which can stimulate the testes to produce sperm. Some men with HH can achieve natural conception after successful treatment. Low testosterone is a hallmark of HH and can be the first clinical finding that leads to the diagnosis.

Cryptorchidism (undescended testes): Testes that did not descend into the scrotum in infancy. Even after surgical correction (orchiopexy), long-term sperm production is often impaired, especially if correction happened after age 2.

Prior chemotherapy or radiotherapy: Alkylating agents (cyclophosphamide, busulfan) and radiation directed at or near the pelvis/testes can cause temporary or permanent azoospermia. Recovery is variable and depends on dose and the patient’s age at treatment. Men who know they will undergo cancer treatment should discuss sperm freezing before starting, as pre-treatment sperm banking is the most reliable fertility preservation option available. Testicular tissue freezing is an option for pre-pubertal boys.

Varicocele: A varicocele (enlarged testicular vein) impairs sperm production through local heat and oxidative stress. In severe cases it can cause azoospermia. Varicocele is the most common surgically correctable cause of male infertility, and varicocele surgery sometimes restores detectable sperm to the ejaculate, making it worth treating before proceeding to micro-TESE.

Sertoli cell-only syndrome: The seminiferous tubules contain only support cells (Sertoli cells) with no germ cells to develop into sperm. In many cases this is idiopathic. Prognosis for sperm retrieval is poor but not zero; focal areas of spermatogenesis may exist.

How Azoospermia Is Diagnosed?

Azoospermia is confirmed only after two separate semen analyses with centrifugation. A single borderline result is not sufficient for diagnosis. Once confirmed, the following investigations distinguish type and cause:

Hormone panel (blood test): FSH, LH, testosterone, prolactin. High FSH with low testosterone points to primary testicular failure (NOA). Normal FSH with azoospermia suggests either obstruction or a pre-testicular (pituitary) cause.

Genetic testing:

• Karyotype analysis (chromosomal testing) to detect Klinefelter syndrome and other chromosomal abnormalities.
• Y-chromosome microdeletion analysis to detect AZFa, AZFb, AZFc deletions.
• CFTR mutation testing if CBAVD is suspected (confirmed by absence of vas deferens on physical examination or ultrasound).

Scrotal and transrectal ultrasound: Identifies varicocele, measures testicular volume (small testes suggest NOA), and detects ejaculatory duct obstruction or other structural issues.

Testicular biopsy: Sometimes performed as both a diagnostic procedure (confirming sperm production status) and a therapeutic procedure (retrieving sperm for freezing). The advanced tests for azoospermia at Mamata Fertility integrate all these assessments systematically.

Treatment: Obstructive Azoospermia

The prognosis for OA is the most favourable of any azoospermia category. Sperm quality is typically good because the testes have been producing them normally. The question is simply how to retrieve them.

PESA (percutaneous epididymal sperm aspiration): A fine needle is inserted into the epididymis (the coiled tube where sperm mature and gain motility, located behind the testis) and sperm are aspirated. Minimally invasive, can be performed under local anaesthesia. PESA is the first-line retrieval method for OA and retrieves mature, motile sperm in the vast majority of cases.

TESA (testicular sperm aspiration): A fine needle aspiration directly from the testicular tissue. Used when PESA is unsuccessful or as an alternative. TESA retrieves sperm that are slightly less mature than epididymal sperm but are still suitable for ICSI.

Vasectomy reversal (vasovasostomy): Surgical reconnection of the vas deferens. Best suited to men whose vasectomy was performed fewer than 10 years ago. Patency rates (open vas) are high when performed within 10 years but decline significantly beyond 15 years, partly due to anti-sperm antibody formation. For men with longer intervals or for whom reconnection has failed, PESA + ICSI is the standard alternative.

Surgical correction of ejaculatory duct obstruction: TURED (transurethral resection of the ejaculatory ducts) can restore sperm to the ejaculate in select cases. Outcomes are variable and depend on the extent of obstruction.

Treatment: Non-Obstructive Azoospermia

NOA treatment is more nuanced. The goal is either to restore sperm to the ejaculate (where possible) or to surgically retrieve the focal sperm that do exist for use in ICSI.

Treat correctable causes first:

For men with varicocele and NOA, varicocele surgery is recommended before micro-TESE in appropriate candidates. A proportion of men develop detectable sperm in the ejaculate after varicocele repair, which avoids the need for surgical retrieval altogether. Even in men who remain azoospermic, varicocele repair may improve the chance of sperm retrieval at subsequent micro-TESE.

For men with hypogonadotropic hypogonadism, gonadotropin therapy (hCG injections initially, then adding FSH) stimulates the testes to begin sperm production. Treatment typically takes 12-18 months to produce detectable sperm. This is one of the few NOA scenarios where natural conception after treatment is a realistic outcome. The decision to pursue gonadotropin therapy versus proceeding directly to sperm retrieval depends on the severity of HH and the couple’s timeline.

Micro-TESE for non-correctable NOA:

TESE (testicular sperm extraction) and micro-TESE are the definitive sperm retrieval procedures for NOA. The microsurgical approach (micro-TESE) is now the gold standard because it:

• Identifies sperm-producing tubules (which appear larger and whiter under the microscope) with greater precision than standard TESE
• Retrieves more sperm from less testicular tissue
• Causes less post-operative damage to testicular function (testosterone-producing Leydig cells are better preserved)
• Achieves higher overall sperm retrieval rates (40-60% vs 30-50% for conventional TESE)

Sperm retrieval rates by NOA cause:

These ranges are from the peer-reviewed literature and represent pooled data across centres. Individual outcomes at any centre depend on surgical volume and laboratory quality.

ICSI: Turning Retrieved Sperm Into a Pregnancy

Once sperm are retrieved, ICSI is the fertilisation method used in virtually all cases. A single sperm is injected directly into each mature egg. This bypasses the need for sperm to swim and penetrate the egg independently, making it effective even with immotile or few sperm.

What to expect:

Fertilisation rates after ICSI with surgically retrieved sperm are approximately 60-70% in OA cases and 50-65% in NOA cases. Not every fertilised egg becomes a viable blastocyst for transfer. Live birth rates per ICSI cycle for azoospermia depend heavily on female age and embryo quality, not just sperm source.

For couples where the female partner is under 35 and sperm retrieval is successful, cumulative live birth rates across 2-3 ICSI cycles are generally in the range of 50-70% for OA and 30-50% for NOA. These figures are estimates; the most accurate prognosis comes from a consultation that considers both partners’ individual factors.

Surplus embryos of good quality can be frozen for future cycles, improving cumulative outcomes without the need for repeated sperm retrieval.

Pre-implantation genetic testing (PGT-A): For couples where the male partner has Klinefelter syndrome or a Y-chromosome microdeletion, PGT-A (preimplantation genetic testing for aneuploidies) is often recommended to select chromosomally normal embryos before transfer, reducing miscarriage risk.

What If No Sperm Is Found at Micro-TESE?

This is the conversation no one wants to have, but it is medically important.

In approximately 40-60% of NOA cases, micro-TESE finds no sperm. If this occurs, the couple’s options include:

Repeat micro-TESE: A second attempt 6-12 months later at a high-volume centre with microsurgical expertise sometimes succeeds when an initial attempt failed, particularly if the initial attempt was not performed under an operating microscope.

Donor sperm with IVF or IUI: Sperm from an anonymous ICMR-registered donor allows the female partner to carry and deliver a genetically related child. This is an established, legal option under India’s ART (Regulation) Act, 2021.

Adoption: A pathway some couples choose when other options are not pursued or are unsuccessful.

The conversation about backup planning should happen before the retrieval attempt, not after, so couples are emotionally and logistically prepared for any outcome.

When Can Natural Conception Still Happen?

Azoospermia typically means natural conception is not possible. However, there are specific, narrow exceptions:

Hypogonadotropic hypogonadism after successful treatment: After 12-18 months of gonadotropin therapy (hCG + FSH), sperm may appear in the ejaculate. Some men achieve sperm counts sufficient for natural conception, though most will still have low sperm count rather than a fully normal count, and may require IUI or ICSI.

Varicocele repair in NOA with varicocele: A minority of NOA men with varicocele develop detectable ejaculatory sperm after varicocele surgery. Natural conception then becomes theoretically possible, though the sperm count is usually low and assisted reproduction is more likely needed.

Vasectomy reversal (vasovasostomy): Restores ejaculatory sperm in a high proportion of cases when performed within 10 years of vasectomy. Natural conception is achievable in many couples, depending on the female partner’s fertility.

All other causes of azoospermia, including Klinefelter syndrome, complete AZF deletions, and Sertoli cell-only syndrome, do not resolve to allow natural conception. Surgical sperm retrieval with ICSI is the only biological parenthood option, if sperm can be found.

What the Evidence Says?

“Micro-TESE is the gold standard for sperm retrieval in non-obstructive azoospermia, with sperm retrieval rates of 43-63% reported across studies, significantly higher than conventional TESE.” Schlegel PN (2009). Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Human Reproduction, 14(1), 131-135.

“Y-chromosome AZFa and AZFb complete deletions are associated with Sertoli cell-only or maturation arrest phenotype, and sperm retrieval is extremely unlikely. AZFc deletions are compatible with residual spermatogenesis and positive micro-TESE outcomes in the majority of cases.” Krausz C, Navarro-Costa P, Rebelo SB (2020). AZF deletions. Encyclopedia of Reproduction (2nd ed.), Elsevier.

“In men with Klinefelter syndrome, successful micro-TESE followed by ICSI results in fertilisation rates of approximately 50-60% and live birth rates comparable to other NOA etiologies.” Corona G et al. (2017). Sperm recovery and ICSI outcomes in Klinefelter syndrome. Human Reproduction Update, 23(3).

Expert Perspective

“A zero sperm count in the ejaculate is not the end of the story. What matters immediately after that diagnosis is understanding the type, and that requires proper investigation. I see men who have been told they cannot have children when, in fact, they have obstructive azoospermia with perfectly normal sperm production waiting in the testes. I also see men with non-obstructive azoospermia who choose micro-TESE and become fathers. The workup is not a formality. It is what determines which path is available to you and, in some cases, what can be done to improve your odds before surgery. Skipping the genetic testing to save time can lead to a procedure with near-zero probability of success. That is a mistake we work hard to prevent.”

Dr. Aarti Deenadayal Tolani, MD (OBG), FICOG, Fellowship in Reproductive Medicine Medical Director, Mamata Fertility Hospital, Hyderabad

What Is the Treatment for Azoospermia?

Azoospermia treatment depends on the type. Obstructive azoospermia is treated with surgical sperm retrieval (PESA from the epididymis or TESA from the testis) followed by ICSI. Success rates are high. Non-obstructive azoospermia is treated with micro-TESE (microsurgical testicular sperm extraction), which finds sperm in 40-60% of cases; if found, ICSI achieves fertilisation. Correctable NOA causes (varicocele, hypogonadotropic hypogonadism) are treated first, as some men develop ejaculatory sperm after treatment. (Schlegel 2009; Krausz 2020)

Can You Get Pregnant If Your Partner Has Zero Sperm Count?

Yes, in most cases. For obstructive azoospermia, sperm retrieved from the epididymis or testis are used in ICSI to fertilise eggs, with live birth rates comparable to standard IVF for couples where the female partner is under 35. For non-obstructive azoospermia, micro-TESE finds sperm in 40-60% of cases; if sperm are found, pregnancy is achievable through ICSI. Where no sperm are found at surgery, donor sperm is an alternative. (WHO; Schlegel PN 2009)

What Is the Difference Between Obstructive and Non-Obstructive Azoospermia?

Obstructive azoospermia (OA) is caused by a blockage in the reproductive tract that prevents sperm from reaching the ejaculate, even though the testes produce sperm normally. Common causes include vasectomy, absent vas deferens, and prior infection. Non-obstructive azoospermia (NOA) is caused by impaired sperm production in the testes themselves. Causes include Klinefelter syndrome, Y-chromosome microdeletions, varicocele, prior chemotherapy, and hormonal disorders. OA has a significantly better prognosis for sperm retrieval and pregnancy.

When to Book a Consultation?

A diagnosis of azoospermia on a semen analysis should be followed promptly by specialist evaluation, not repeated home testing or a wait-and-see approach. Time matters because female partner age affects IVF outcomes, and some treatment pathways (gonadotropin therapy, varicocele repair before micro-TESE) take months to complete.

The advanced azoospermia diagnostic workup at Mamata Fertility Hospital integrates hormone testing, genetic analysis, imaging, and specialist consultation into a structured evaluation. Our male fertility team includes experience in micro-TESE, PESA, TESA, and ICSI across all azoospermia causes, including complex cases such as Klinefelter syndrome and post-chemotherapy NOA.

Book a consultation at Mamata Fertility Hospital

See our full male fertility treatment options in Hyderabad for an overview of what is available.

FAQ